MICHELE HOPKINS: Open Payments
NPI 1750067278 · SAGINAW, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,086 in 11 payments from 10 companies in 2025. Trend: 2023 $1,370 · 2024 $2,255 · 2025 $1,086
Food & beverage: $1,086
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 2 | $224 |
| Braeburn Inc. | 1 | $126 |
| ABBVIE INC. | 1 | $125 |
| Gilead Sciences, Inc. | 1 | $122 |
| Teva Pharmaceuticals USA, Inc. | 1 | $121 |
| Janssen Pharmaceuticals, Inc | 1 | $107 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $101 |
| Alkermes, Inc. | 1 | $67 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $50 |
| COLOPLAST CORP | 1 | $44 |
Products named: Auvelity, BRIXADI, VRAYLAR, Epclusa, SPRAVATO, REXULTI, LYBALVI, LifeVest.
Industry payments across MI — which companies pay providers there.
